Skip to main content
Signal8

Watanabe Todd

SEC insider (Form 3/4/5 filer). CIK 0001801061. Director at Arcutis Biotherapeutics, Inc. (ARQT). 33 reported Form 4/5 transactions since Sep 2024; latest on Aug 3, 2026. Located in WESTLAKE VILLAGE, CA.

Companies Watanabe Todd has filed insider reports for

  • Arcutis Biotherapeutics, Inc. (ARQT): Director, Officer, See Remarks
Watanabe Todd profile photo

Watanabe Todd

CIK: 0001801061

Transaction Breakdown

Open Market Buys (P)2 (6.1%)

High conviction signal

Open Market Sales (S)25 (75.8%)

Position reduction

Option Exercises (M)0 (0.0%)

Derivative conversions

Awards (A)2 (6.1%)

Compensation grants

Other (G, F, J, C, D, …)4 (12.1%)

Gifts, tax withholding, conversions, dispositions to the issuer and other codes

Companies & Roles (1)

Arcutis Biotherapeutics, Inc. logo
ARQT

Arcutis Biotherapeutics, Inc.

DirectorOfficer

Discretionary Trading P&L

Holdings

Transaction History (33 total)

  • Arcutis Biotherapeutics, Inc. logo
    ARQT

    Arcutis Biotherapeutics, Inc.

    Aug 3, 2026
    Sale
    Direct
    4.4K shares at avg. $26.12$114K
  • Arcutis Biotherapeutics, Inc. logo
    ARQT

    Arcutis Biotherapeutics, Inc.

    May 4, 2026
    Sale
    Direct
    3.2K shares at avg. $23.61$75K
  • Arcutis Biotherapeutics, Inc. logo
    ARQT

    Arcutis Biotherapeutics, Inc.

    Mar 2, 2026
    Sale
    Direct
    1.1K shares at avg. $25.91$28K
  • Arcutis Biotherapeutics, Inc. logo
    ARQT

    Arcutis Biotherapeutics, Inc.

    Mar 2, 2026
    Sale
    Direct
    36.3K shares at avg. $25.16$913K
  • Arcutis Biotherapeutics, Inc. logo
    ARQT

    Arcutis Biotherapeutics, Inc.

    Feb 27, 2026
    Award
    Direct
    102K shares-
  • Arcutis Biotherapeutics, Inc. logo
    ARQT

    Arcutis Biotherapeutics, Inc.

    Feb 2, 2026
    Sale
    Direct
    19.8K shares at avg. $25.50$506K
  • Arcutis Biotherapeutics, Inc. logo
    ARQT

    Arcutis Biotherapeutics, Inc.

    Nov 24, 2025
    Sale
    Direct
    48.9K shares at avg. $30.36$1.5M
  • Arcutis Biotherapeutics, Inc. logo
    ARQT

    Arcutis Biotherapeutics, Inc.

    Nov 21, 2025
    Sale
    Direct
    1.1K shares at avg. $30.00$32K
  • Arcutis Biotherapeutics, Inc. logo
    ARQT

    Arcutis Biotherapeutics, Inc.

    Nov 3, 2025
    Sale
    Direct
    69 shares at avg. $25.40$2K
  • Arcutis Biotherapeutics, Inc. logo
    ARQT

    Arcutis Biotherapeutics, Inc.

    Nov 3, 2025
    Sale
    Direct
    11.5K shares at avg. $24.71$284K

1-10 of 33